Compare NRXP & FURY Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
Current Price
Current Price
| Metric | NRXP | FURY |
|---|---|---|
| Founded | 2015 | 2008 |
| Country | United States | Canada |
| Employees | 29 | N/A |
| Industry | Biotechnology: Pharmaceutical Preparations | Precious Metals |
| Sector | Health Care | Basic Materials |
| Exchange | Nasdaq | Nasdaq |
| Market Cap | 99.2M | 97.7M |
| IPO Year | N/A | 2011 |
| Metric | NRXP | FURY |
|---|---|---|
| Price | $3.30 | $0.60 |
| Analyst Decision | Strong Buy | Strong Buy |
| Analyst Count | 4 | 2 |
| Target Price | ★ $38.25 | $1.70 |
| AVG Volume (30 Days) | ★ 1.2M | 364.3K |
| Earning Date | 05-14-2026 | 08-11-2026 |
| Dividend Yield | N/A | N/A |
| EPS Growth | N/A | N/A |
| EPS | N/A | N/A |
| Revenue | N/A | N/A |
| Revenue This Year | $2,547.84 | N/A |
| Revenue Next Year | $1,591.73 | N/A |
| P/E Ratio | N/A | N/A |
| Revenue Growth | N/A | N/A |
| 52 Week Low | $1.65 | $0.36 |
| 52 Week High | $3.84 | $1.02 |
| Indicator | NRXP | FURY |
|---|---|---|
| Relative Strength Index (RSI) | 66.71 | 46.79 |
| Support Level | $1.98 | $0.57 |
| Resistance Level | $3.29 | $0.63 |
| Average True Range (ATR) | 0.20 | 0.03 |
| MACD | -0.01 | 0.00 |
| Stochastic Oscillator | 69.08 | 54.13 |
NRX Pharmaceuticals Inc is a clinical-stage, small-molecule pharmaceutical company that develops and plans to distribute novel therapeutics for the treatment of central nervous system disorders and life-threatening pulmonary diseases. The company is developing NRX-100/101, the first sequential drug regimen for bipolar depression in patients with acute suicidal ideation and behavior.
Fury Gold Mines Ltd is a Canadian-focused exploration and development company strategically positioned in three prolific mining regions: James Bay, Quebec; the Golden Triangle, British Columbia; and the Kitikmeot Region Nunavut. Its projects include Eau Claire, Homestake Ridge, Committee Bay, Eleonore South JV, and Gibson MacQuoid.